The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-tumor necrosis factor therapy in inflammatory bowel disease

The development of biological agents against tumor necrosis factor (TNF) has revolutionized the management of inflammatory bowel disease (IBD), frequently achieving induction and maintenance of remission in both ulcerative colitis and Crohn’s disease. However, a loss of response due to the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Fousekis, Fotios S., Papamichael, Konstantinos, Kourtis, Georgios, Albani, Eleni N., Orfanidou, Afroditi, Saridi, Maria, Katsanos, Konstantinos H., Christodoulou, Dimitrios K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713338/
https://www.ncbi.nlm.nih.gov/pubmed/34987282
http://dx.doi.org/10.20524/aog.2021.0682

Ejemplares similares

Ejemplares similares